| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.6M | -17.2% | -91.8% |
| R&D Expense | $38.4M | +1.3% | +22.7% |
| SG&A Expense | $10.3M | -5.7% | +3.3% |
| Operating Income | -$47.1M | -0.4% | -117.2% |
| Income Tax | $654K | +267.4% | +135.2% |
| Net Income | -$44.1M | -2.4% | -214.5% |
| EPS (Basic) | -$1.06 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $93.3M | +28.7% | +19.5% |
| Current Assets | $338.3M | -8.4% | -27.3% |
| Total Assets | $412.9M | -8.0% | -25.5% |
| Current Liabilities | $24.0M | +21.3% | -66.0% |
| Total Liabilities | $72.2M | +4.2% | -45.4% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$96.3M | — | — |
| Capital Expenditures | $1.2M | — | — |
| Investing Cash Flow | $87.7M | — | — |
| Financing Cash Flow | $695K | — | — |
| Free Cash Flow | -$97.6M | — | — |
| -1.9% |
| -202.9% |
| EPS (Diluted) | -$1.06 | -1.9% | -202.9% |
| $340.7M |
| -10.2% |
| -19.3% |